A. Rosengren, L. Wallentin, and M. Simoons, Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey, European Heart Journal, vol.27, issue.7, pp.789-795, 2006.
DOI : 10.1093/eurheartj/ehi774

G. Devlin, J. Gore, and J. Elliott, Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events, European Heart Journal, vol.29, issue.10
DOI : 10.1093/eurheartj/ehn124

K. Alexander, M. Roe, and A. Chen, Evolution in Cardiovascular Care for Elderly Patients With Non???ST-Segment Elevation Acute Coronary Syndromes, Journal of the American College of Cardiology, vol.46, issue.8, pp.1479-1487, 2005.
DOI : 10.1016/j.jacc.2005.05.084

K. Alexander, L. Newby, and C. Cannon, Acute Coronary Care in the Elderly, Part I: Non-ST-Segment-Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology, Circulation, vol.115, issue.19, pp.2549-2569, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.182615

E. Lakatta, Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging, Circulation, vol.107, issue.3, pp.490-497, 2003.
DOI : 10.1161/01.CIR.0000048894.99865.02

E. Lakatta and D. Levy, Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: A "Set Up" for Vascular Disease, Circulation, vol.107, issue.1, pp.139-146, 2003.
DOI : 10.1161/01.CIR.0000048892.83521.58

A. Fagot-campagna, I. Bourdel-marchasson, and D. Simon, Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care, Diabetes & Metabolism, vol.31, issue.2, pp.5-35, 2005.
DOI : 10.1016/S1262-3636(05)73650-8

N. Kagansky, S. Levy, Y. Berner, E. Rimon, and H. Knobler, Cholesterol lowering in the older population: time for reassessment?, QJM, vol.94, issue.9, pp.457-463, 2001.
DOI : 10.1093/qjmed/94.9.457

E. Ford, Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome: A summary of the evidence, Diabetes Care, vol.28, issue.7, pp.1769-1778, 2005.
DOI : 10.2337/diacare.28.7.1769

J. Cambou, T. Simon, G. Mulak, V. Bataille, and N. Danchin, The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics, Arch Mal Coeur Vaiss, vol.100, pp.524-534, 2007.

B. Metz, H. White, and C. Granger, Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial, Journal of the American College of Cardiology, vol.31, issue.7, pp.1493-1498, 1998.
DOI : 10.1016/S0735-1097(98)00138-7

. Anon, International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network, Circulation, vol.97, pp.2386-2395, 1998.

D. Mukherjee, K. Mahaffey, and D. Moliterno, Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B), American Heart Journal, vol.144, issue.6
DOI : 10.1067/mhj.2002.126118

. Anon, Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators

I. Platelet-glycoprotein, IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy, N. Engl. J. Med, vol.339, pp.436-443, 1998.

M. Simoons, Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial, Lancet, vol.357, pp.1915-1924, 2001.

D. Kandzari, M. Roe, and A. Chen, Influence of clinical trial enrollment on the quality of care and outcomes for patients with non???ST-segment elevation acute coronary syndromes, American Heart Journal, vol.149, issue.3, pp.474-481, 2005.
DOI : 10.1016/j.ahj.2004.11.014

M. Davies, CORONARY DISEASE: The pathophysiology of acute coronary syndromes, Heart, vol.83, issue.3, pp.361-366, 2000.
DOI : 10.1136/heart.83.3.361

P. Libby, Current Concepts of the Pathogenesis of the Acute Coronary Syndromes, Circulation, vol.104, issue.3, pp.365-372, 2001.
DOI : 10.1161/01.CIR.104.3.365

E. Falk, Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion, Circulation, vol.71, issue.4, pp.699-708, 1985.
DOI : 10.1161/01.CIR.71.4.699

M. Davies, A. Thomas, P. Knapman, and J. Hangartner, Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death, Circulation, vol.73, issue.3, pp.418-427, 1986.
DOI : 10.1161/01.CIR.73.3.418

J. Canto, C. Fincher, and C. Kiefe, Atypical presentations among medicare beneficiaries with unstable angina pectoris**This material was prepared by the Alabama Quality Assurance Foundation under a contract with the Centers for Medicare and Medicaid Services (CMS). Contents do not necessarily represent CMS policy., The American Journal of Cardiology, vol.90, issue.3, pp.248-253, 2002.
DOI : 10.1016/S0002-9149(02)02463-3

V. Culi?, D. Eterovi?, D. Miri?, and N. Sili?, Symptom presentation of acute myocardial infarction: Influence of sex, age, and risk factors, American Heart Journal, vol.144, issue.6, pp.1012-1017, 2002.
DOI : 10.1067/mhj.2002.125625

R. Wright, J. Anderson, and C. Adams, AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J. Am, 2011.

E. Braunwald, E. Antman, and J. Beasley, ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina), Circulation, vol.106, issue.14, pp.1893-1900, 2002.
DOI : 10.1161/01.CIR.0000037106.76139.53

C. Hamm, J. Bassand, and S. Agewall, ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation, Revista Espa??ola de Cardiolog??a (English Edition), vol.65, issue.2, pp.26-2011
DOI : 10.1016/j.rec.2011.11.006

URL : https://hal.archives-ouvertes.fr/hal-01478204

D. Diercks, W. Peacock, and B. Hiestand, Frequency and Consequences of Recording an Electrocardiogram >10 Minutes After Arrival in an Emergency Room in Non???ST-Segment Elevation Acute Coronary Syndromes (from the CRUSADE Initiative), The American Journal of Cardiology, vol.97, issue.4, pp.437-442, 2006.
DOI : 10.1016/j.amjcard.2005.09.073

K. Thygesen, J. Alpert, and H. White, Universal Definition of Myocardial Infarction, Circulation, vol.116, issue.22, pp.2634-2653, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.187397

J. De-lemos, D. Morrow, and J. Bentley, The prognostic value of Btype natriuretic peptide in patients with acute coronary syndromes, N. Engl

T. Jernberg, M. Stridsberg, P. Venge, and B. Lindahl, N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation, Journal of the American College of Cardiology, vol.40, issue.3, pp.437-445, 2002.
DOI : 10.1016/S0735-1097(02)01986-1

G. Liuzzo, L. Biasucci, and J. Gallimore, The prognostic value of Creactive protein and serum amyloid a protein in severe unstable angina, N

D. Morrow, N. Rifai, and E. Antman, C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy, Journal of the American College of Cardiology, vol.31, issue.7, pp.1460-1465, 1998.
DOI : 10.1016/S0735-1097(98)00136-3

A. Suwaidi, J. Reddan, D. Williams, and K. , Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes, Circulation, vol.106, issue.8, pp.974-980, 2002.
DOI : 10.1161/01.CIR.0000027560.41358.B3

F. Masoudi, M. Plomondon, D. Magid, A. Sales, and J. Rumsfeld, Renal insufficiency and mortality from acute coronary syndromes, American Heart Journal, vol.147, issue.4, pp.623-629, 2004.
DOI : 10.1016/j.ahj.2003.12.010

M. Cheitlin, W. Armstrong, and G. Aurigemma, ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography), American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography, pp.1146-1162, 2003.
DOI : 10.1161/01.CIR.0000073597.57414.A9

K. Eagle, M. Lim, and O. Dabbous, A Validated Prediction Model for All Forms of Acute Coronary Syndrome, JAMA, vol.291, issue.22, pp.2727-2733, 2004.
DOI : 10.1001/jama.291.22.2727

K. Fox, O. Dabbous, and R. Goldberg, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), BMJ, vol.333, issue.7578
DOI : 10.1136/bmj.38985.646481.55

C. Granger, R. Goldberg, and O. Dabbous, Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events, Archives of Internal Medicine, vol.163, issue.19, pp.2345-2353, 2003.
DOI : 10.1001/archinte.163.19.2345

P. De-araújo-gonçalves, J. Ferreira, C. Aguiar, R. Seabra-gomes, . Timi et al., TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE???ACS, European Heart Journal, vol.26, issue.9, pp.865-872, 2005.
DOI : 10.1161/01.CIR.0000027560.41358.B3

E. Antman, M. Cohen, and P. Bernink, The TIMI Risk Score for Unstable Angina/Non???ST Elevation MI, JAMA, vol.284, issue.7, pp.835-842, 2000.
DOI : 10.1001/jama.284.7.835

B. Lagerqvist, E. Diderholm, and B. Lindahl, FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease, Heart, vol.91, issue.8, pp.1047-1052, 2005.
DOI : 10.1136/hrt.2003.031369

E. Boersma, K. Pieper, and E. Steyerberg, Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation : Results From an International Trial of 9461 Patients, Circulation, vol.101, issue.22, pp.2557-2567, 2000.
DOI : 10.1161/01.CIR.101.22.2557

S. Subherwal, R. Bach, and A. Chen, Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score, Circulation, vol.119, issue.14, pp.1873-1882, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.828541

R. Mehran, S. Pocock, and E. Nikolsky, A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes, Journal of the American College of Cardiology, vol.55, issue.23, pp.2556-2566, 2010.
DOI : 10.1016/j.jacc.2009.09.076

G. Stone, M. Bertrand, and A. Colombo, Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale, American Heart Journal, vol.148, issue.5, pp.764-775, 2004.
DOI : 10.1016/j.ahj.2004.04.036

R. Mehran, B. Brodie, and D. Cox, The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale, American Heart Journal, vol.156, issue.1, pp.44-56, 2008.
DOI : 10.1016/j.ahj.2008.02.008

D. Brieger, K. Eagle, and S. Goodman, Acute Coronary Syndromes Without Chest Pain, An Underdiagnosed and Undertreated High-Risk Group, Chest, vol.126, issue.2, pp.461-469, 2004.
DOI : 10.1378/chest.126.2.461

W. Kannel and R. Abbott, Incidence and Prognosis of Unrecognized Myocardial Infarction, New England Journal of Medicine, vol.311, issue.18, pp.1144-1147, 1984.
DOI : 10.1056/NEJM198411013111802

G. Gregoratos, Clinical Manifestations of Acute Myocardial Infarction in Older Patients, The American Journal of Geriatric Cardiology, vol.11, issue.6, pp.345-347, 2001.
DOI : 10.1016/S0735-1097(96)82269-8

J. Bassand, C. Hamm, and D. Ardissino, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

W. Wijns, P. Kolh, and N. Danchin, Guidelines on myocardial revascularization, Revista Portuguesa de Cardiologia (English Edition), vol.30, issue.12, pp.2501-2555, 2010.
DOI : 10.1016/j.repce.2011.11.010

K. Fox, T. Clayton, and P. Damman, Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data, J. Am

S. Mehta, C. Granger, and W. Boden, Early versus Delayed Invasive Intervention in Acute Coronary Syndromes, New England Journal of Medicine, vol.360, issue.21, pp.2165-2175, 2009.
DOI : 10.1056/NEJMoa0807986

P. Sorajja, B. Gersh, and D. Cox, Impact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management, Journal of the American College of Cardiology, vol.55, issue.14, pp.1416-1424, 2010.
DOI : 10.1016/j.jacc.2009.11.063

I. Nyman, L. Wallentin, M. Areskog, N. Areskog, and E. Swahn, Risk stratification by early exercise testing after an episode of unstable coronary artery disease, International Journal of Cardiology, vol.39, issue.2, pp.131-142, 1993.
DOI : 10.1016/0167-5273(93)90024-B

E. Amsterdam, J. Kirk, D. Diercks, W. Lewis, and S. Turnipseed, Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain, Journal of the American College of Cardiology, vol.40, issue.2, pp.251-256, 2002.
DOI : 10.1016/S0735-1097(02)01968-X

S. Mehta, C. Cannon, and K. Fox, Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes, JAMA, vol.293, issue.23, pp.2908-2917, 2005.
DOI : 10.1001/jama.293.23.2908

. Anon, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial Thrombolysis in Myocardial Ischemia, Circulation, vol.89, pp.1545-1556, 1994.

W. Boden, R. O-'rourke, and M. Crawford, Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy Veterans Affairs

P. Mccullough, O. Neill, W. Graham, and M. , A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy, Journal of the American College of Cardiology, vol.32, issue.3, pp.596-605, 1998.
DOI : 10.1016/S0735-1097(98)00284-8

B. Lagerqvist, S. Husted, and F. Kontny, 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study, The Lancet, vol.368, issue.9540, pp.998-1004, 2006.
DOI : 10.1016/S0140-6736(06)69416-6

E. Diderholm, B. Andrén, and G. Frostfeldt, The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: The FRISC II invasive troponin T electrocardiogram substudy, American Heart Journal, vol.143, issue.5, pp.760-767, 2002.
DOI : 10.1067/mhj.2002.121733

B. Lagerqvist, S. Husted, and F. Kontny, A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study, ACC Current Journal Review, vol.12, issue.2, pp.1902-1914, 2002.
DOI : 10.1016/S1062-1458(03)00082-5

C. Cannon, W. Weintraub, and L. Demopoulos, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb

. Anon, Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial, Lancet, vol.358, pp.951-957, 2001.

M. Pfisterer, Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME), Circulation, vol.110, issue.10, pp.1213-1218, 2004.
DOI : 10.1161/01.CIR.0000140983.69571.BA

F. Filsoufi, P. Rahmanian, and J. Castillo, Results and Predictors of Early and Late Outcomes of Coronary Artery Bypass Graft Surgery in Octogenarians, Journal of Cardiothoracic and Vascular Anesthesia, vol.21, issue.6, pp.784-792, 2007.
DOI : 10.1053/j.jvca.2007.08.007

E. Jones, Coronary bypass surgery in the elderly Dans: Coronary Heart Disease in the Elderly, pp.375-88

D. Cosgrove, Surgical myocardial revascularization, Cardiology in the Elderly.Vol, vol.1, issue.1993, pp.71-77

E. Peterson, P. Cowper, and J. Jollis, Outcomes of Coronary Artery Bypass Graft Surgery in 24 461 Patients Aged 80 Years or Older, Circulation, vol.92, issue.9, pp.85-91, 1995.
DOI : 10.1161/01.CIR.92.9.85

J. Ivanov, R. Weisel, T. David, and C. Naylor, Fifteen-Year Trends in Risk Severity and Operative Mortality in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery, Circulation, vol.97, issue.7, pp.673-680, 1998.
DOI : 10.1161/01.CIR.97.7.673

E. Peterson, J. Jollis, and J. Bebchuk, Changes in Mortality after Myocardial Revascularization in the Elderly: The National Medicare Experience, Annals of Internal Medicine, vol.121, issue.12, pp.919-927, 1994.
DOI : 10.7326/0003-4819-121-12-199412150-00003

W. Freeman, H. Schaff, O. Brien, and P. , Cardiac surgery in the octogenarian: Perioperative outcome and clinical follow-up, Journal of the American College of Cardiology, vol.18, issue.1, pp.29-35, 1991.
DOI : 10.1016/S0735-1097(10)80212-8

T. Kaul, B. Fields, D. Wyatt, C. Jones, and D. Kahn, Angioplasty versus coronary artery bypass in octogenarians, The Annals of Thoracic Surgery, vol.58, issue.5, pp.1419-1426, 1994.
DOI : 10.1016/0003-4975(94)91927-5

W. Ko, J. Gold, and R. Lazzaro, Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment, Circulation, vol.86, issue.5, pp.191-197, 1992.

D. Glower, T. Christopher, and C. Milano, Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years, The American Journal of Cardiology, vol.70, issue.6, pp.567-571, 1992.
DOI : 10.1016/0002-9149(92)90192-2

S. Nashef, F. Roques, and P. Michel, European system for cardiac operative risk evaluation (EuroSCORE), European Journal of Cardio-Thoracic Surgery, vol.28, issue.1, pp.9-13, 1999.
DOI : 10.1016/S0735-1097(96)00359-2

A. Gogbashian, A. Sedrakyan, and T. Treasure, EuroSCORE: a systematic review of international performance, European Journal of Cardio-Thoracic Surgery, vol.25, issue.5, pp.695-700, 2004.
DOI : 10.1016/j.ejcts.2004.02.022

A. Avezum, M. Makdisse, and F. Spencer, Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE), American Heart Journal, vol.149, issue.1, pp.67-73, 2005.
DOI : 10.1016/j.ahj.2004.06.003

. Anon, Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group, Lancet, vol.2, pp.57-66, 1986.

S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight, Beta blockade during and after myocardial infarction: An overview of the randomized trials, Progress in Cardiovascular Diseases, vol.27, issue.5, pp.335-371, 1985.
DOI : 10.1016/S0033-0620(85)80003-7

DOI : 10.1016/S0140-6736(81)92399-0

J. Lubsen and J. Tijssen, Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: Findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT), The American Journal of Cardiology, vol.60, issue.2, pp.18-25, 1987.
DOI : 10.1016/0002-9149(87)90494-2

S. Yusuf, J. Wittes, and L. Friedman, Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification, JAMA: The Journal of the American Medical Association, vol.260, issue.15, pp.2259-2263, 1988.
DOI : 10.1001/jama.260.15.2259

. Anon, Metoprolol in acute myocardial infarction (MIAMI) A randomised placebo-controlled international trial. The MIAMI Trial Research Group

E. Brandler, L. Paladino, and R. Sinert, Does the Early Administration of Beta-blockers Improve the In-hospital Mortality Rate of Patients Admitted with Acute Coronary Syndrome?, Academic Emergency Medicine, vol.10, issue.6 Pt 2, pp.1-10, 2010.
DOI : 10.7326/0003-4819-134-8-200104170-00012

Z. Chen, H. Pan, and Y. Chen, Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, vol.366, pp.1622-1632, 2005.

C. Miller, M. Roe, and J. Mulgund, Impact of Acute Beta-Blocker Therapy for Patients with Non???ST-Segment Elevation Myocardial Infarction, The American Journal of Medicine, vol.120, issue.8
DOI : 10.1016/j.amjmed.2007.04.016

. Anon, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group, Lancet, vol.345, pp.669-685, 1995.

M. Dellborg, G. Gustafsson, and K. Swedberg, Buccal versus intravenous nitroglyerin in unstable angina pectoris, European Journal of Clinical Pharmacology, vol.78, issue.4, pp.5-9, 1991.
DOI : 10.1161/01.CIR.78.4.906

S. Yusuf, R. Collins, S. Macmahon, and R. Peto, EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS, The Lancet, vol.331, issue.8594, pp.1088-1092, 1988.
DOI : 10.1016/S0140-6736(88)91906-X

. Anon, GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico, Lancet, vol.343, pp.1115-1122, 1994.

E. Antman, D. Anbe, and P. Armstrong, ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction), Circulation, vol.110, issue.5, pp.671-719, 2004.
DOI : 10.1161/01.CIR.0000134791.68010.FA

M. Cheitlin, A. Hutter, . Jr, and R. Brindis, Use of sildenafil (Viagra) in patients with cardiovascular disease, Journal of the American College of Cardiology, vol.33, issue.1, pp.273-282, 1999.
DOI : 10.1016/S0735-1097(98)00656-1

S. Fihn, S. Williams, J. Daley, and R. Gibbons, Guidelines for the Management of Patients with Chronic Stable Angina: Treatment, Annals of Internal Medicine, vol.135, issue.8_Part_1
DOI : 10.7326/0003-4819-135-8_Part_1-200110160-00014

. Anon, Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial, Lancet, vol.359, pp.1269-1275, 2002.

W. Stanley and M. Marzilli, Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine, Fundamental and Clinical Pharmacology, vol.48, issue.1, pp.133-145, 2003.
DOI : 10.1053/euhj.2001.2653

P. Held, S. Yusuf, and C. Furberg, Calcium channel blockers in acute myocardial infarction and unstable angina: an overview., BMJ, vol.299, issue.6709, pp.1187-1192, 1989.
DOI : 10.1136/bmj.299.6709.1187

S. Yusuf, C. Pepine, and C. Garces, Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions, The Lancet, vol.340, issue.8829, pp.1173-1178, 1992.
DOI : 10.1016/0140-6736(92)92889-N

J. Rutherford, M. Pfeffer, and L. Moyé, Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators, Circulation, vol.90, issue.4, pp.1731-1738, 1994.
DOI : 10.1161/01.CIR.90.4.1731

. Anon, Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials, ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation, vol.97, pp.2202-2212, 1998.

I. Gustafsson, C. Torp-pedersen, L. Køber, F. Gustafsson, and P. Hildebrandt, Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction, Journal of the American College of Cardiology, vol.34, issue.1, pp.83-89, 1999.
DOI : 10.1016/S0735-1097(99)00146-1

S. Yusuf, P. Sleight, and J. Pogue, Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

R. Ferrari, M. Bertrand, and W. Remme, Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial, Expert Review of Cardiovascular Therapy, vol.27, issue.6, pp.1037-1046, 2007.
DOI : 10.1093/eurheartj/ehi705

G. Dagenais, J. Pogue, K. Fox, M. Simoons, and S. Yusuf, Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, The Lancet, vol.368, issue.9535, pp.581-588, 2006.
DOI : 10.1016/S0140-6736(06)69201-5

N. Danchin, M. Cucherat, and C. Thuillez, Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction, Archives of Internal Medicine, vol.166, issue.7, pp.787-796, 2006.
DOI : 10.1001/archinte.166.7.787

S. Yusuf and J. Pogue, ACE inhibition in stable coronary artery disease, N

S. Yusuf, K. Teo, and J. Pogue, Telmisartan, ramipril, or both in patients at high risk for vascular events, N. Engl. J. Med, vol.358, pp.1547-1559, 2008.

. Anon, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, vol.324, pp.71-86, 2002.

M. Sabatine, C. Cannon, and C. Gibson, Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation, New England Journal of Medicine, vol.352, issue.12, pp.1179-1189, 2005.
DOI : 10.1056/NEJMoa050522

S. Yusuf, F. Zhao, and S. Mehta, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N. Engl. J. Med, vol.345, pp.494-502, 2001.

A. Budaj, S. Yusuf, and S. Mehta, Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups, Circulation, vol.106, issue.13, pp.1622-1626, 2002.
DOI : 10.1161/01.CIR.0000029926.71825.E2

S. Mehta, S. Yusuf, and R. Peters, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, The Lancet, vol.358, issue.9281, pp.527-533, 2001.
DOI : 10.1016/S0140-6736(01)05701-4

. Anon, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), CAPRIE Steering Committee. Lancet, vol.348, pp.1329-1339, 1996.

S. Mehta, J. Bassand, and S. Chrolavicius, Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, N. Engl. J. Med, vol.363, pp.930-942, 2010.

L. Bonello, L. Camoin-jau, and S. Armero, Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis, The American Journal of Cardiology, vol.103, issue.1, pp.5-10, 2009.
DOI : 10.1016/j.amjcard.2008.08.048

T. Höchtl, I. Tentzeris, K. Schrör, and K. Huber, Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agents Available at, Fundam Clin Pharmacol, 2011.

S. Wiviott, E. Braunwald, and C. Mccabe, Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.357, issue.20, pp.2001-2015, 2007.
DOI : 10.1056/NEJMoa0706482

L. Wallentin, R. Becker, and A. Budaj, Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.361, issue.11, pp.1045-1057, 2009.
DOI : 10.1056/NEJMoa0904327

J. Anderson, C. Adams, and E. Antman, ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine, Circulation, vol.116, issue.7, pp.148-304, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.181940

J. Blankenship, Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors, American Heart Journal, vol.138, issue.4, pp.287-296, 1999.
DOI : 10.1053/hj.1999.v138.a100461

. Anon, Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, Lancet, vol.356, pp.2037-2044, 2000.

K. Alexander, A. Chen, and M. Roe, Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non???ST-Segment Elevation Acute Coronary Syndromes, JAMA, vol.294, issue.24, pp.3108-3116, 2005.
DOI : 10.1001/jama.294.24.3108

E. Boersma, R. Harrington, and D. Moliterno, Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials, The Lancet, vol.359, issue.9302, pp.189-198, 2002.
DOI : 10.1016/S0140-6736(02)07442-1

D. Mari, P. Mannucci, and R. Coppola, Hypercoagulability in centenarians: the paradox of successful aging, Blood, vol.85, pp.3144-3149, 1995.

. Anon, Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction, Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N

C. Hamm, C. Heeschen, and B. Goldmann, Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels, c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators, pp.1623-1629, 1999.
DOI : 10.1056/NEJM199905273402103

C. Heeschen, C. Hamm, and B. Goldmann, Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban, The Lancet, vol.354, issue.9192, pp.1757-1762, 1999.
DOI : 10.1016/S0140-6736(99)10285-X

M. Roffi, D. Chew, and D. Mukherjee, Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non-ST-Segment-Elevation Acute Coronary Syndromes, Circulation, vol.104, issue.23, pp.2767-2771, 2001.
DOI : 10.1161/hc4801.100029

R. Giugliano, J. White, and C. Bode, Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes, New England Journal of Medicine, vol.360, issue.21, pp.2176-2190, 2009.
DOI : 10.1056/NEJMoa0901316

G. Stone, M. Bertrand, and J. Moses, Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes, JAMA, vol.297, issue.6, pp.591-602, 2007.
DOI : 10.1001/jama.297.6.591

P. Albaladejo, E. Marret, V. Piriou, and C. Samama, Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force, British Journal of Anaesthesia, vol.97, issue.4, pp.580-582, 2006.
DOI : 10.1093/bja/ael228

R. Harrington, R. Becker, and C. Cannon, Antithrombotic Therapy for Non???ST-Segment Elevation Acute Coronary Syndromes, Chest, vol.133, issue.6, pp.670-707, 2008.
DOI : 10.1378/chest.08-0691

J. Eikelboom, S. Anand, and K. Malmberg, Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis, The Lancet, vol.355, issue.9219, pp.1936-1942, 2000.
DOI : 10.1016/S0140-6736(00)02324-2

S. Yusuf, S. Mehta, and S. Chrolavicius, Comparison of fondaparinux and enoxaparin in acute coronary syndromes, N. Engl. J. Med, vol.354, pp.1464-1476, 2006.

M. Cohen, C. Demers, and E. Gurfinkel, A comparison of lowmolecular-weight heparin with unfractionated heparin for unstable coronary artery disease, Efficacy and Safety of Subcutaneous Enoxaparin

. Anon, Long-term low-molecular-mass heparin in unstable coronaryartery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease, Investigators. Lancet, vol.354, pp.701-707, 1999.

P. Théroux, H. Ouimet, and J. Mccans, Aspirin, Heparin, or Both to Treat Acute Unstable Angina, New England Journal of Medicine, vol.319, issue.17, pp.1105-1111, 1988.
DOI : 10.1056/NEJM198810273191701

J. Petersen, K. Mahaffey, and V. Hasselblad, Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview, JAMA, vol.292, pp.89-96, 2004.

M. Cohen, C. Demers, and E. Gurfinkel, Low-molecular-weight heparins in non???ST-segment elevation ischemia: the ESSENCE trial, The American Journal of Cardiology, vol.82, issue.5, pp.19-24, 1998.
DOI : 10.1016/S0002-9149(98)00108-8

C. Cannon, E. Braunwald, and C. Mccabe, Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes, New England Journal of Medicine, vol.350, issue.15, pp.1495-1504, 2004.
DOI : 10.1056/NEJMoa040583

. Anon and . Mrc, BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial, Lancet, vol.360, pp.7-22, 2002.

J. Larosa, S. Grundy, and D. Waters, Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease, New England Journal of Medicine, vol.352, issue.14, pp.1425-1435, 2005.
DOI : 10.1056/NEJMoa050461

. Anon, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

P. Sever, B. Dahlöf, and N. Poulter, Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial, The Lancet, vol.361, issue.9364, pp.1149-1158, 2003.
DOI : 10.1016/S0140-6736(03)12948-0

P. Ridker, C. Cannon, and D. Morrow, C-Reactive Protein Levels and Outcomes after Statin Therapy, New England Journal of Medicine, vol.352, issue.1, pp.20-28, 2005.
DOI : 10.1056/NEJMoa042378

J. Shepherd, G. Blauw, and M. Murphy, Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial, The Lancet, vol.360, issue.9346, pp.1623-1630, 2002.
DOI : 10.1016/S0140-6736(02)11600-X

R. Collins, J. Armitage, S. Parish, P. Sleight, and R. Peto, Effects of cholesterollowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions, Lancet, vol.363, pp.757-767, 2004.

J. Afilalo, G. Duque, and R. Steele, Statins for Secondary Prevention in Elderly Patients, Journal of the American College of Cardiology, vol.51, issue.1, pp.37-45, 2008.
DOI : 10.1016/j.jacc.2007.06.063

D. Sparrow and T. Dawber, The influence of cigarette smoking on prognosis after a first myocardial infarction, Journal of Chronic Diseases, vol.31, issue.6-7, pp.425-432, 1978.
DOI : 10.1016/0021-9681(78)90006-1

O. Connor, G. Buring, J. Yusuf, and S. , An overview of randomized trials of rehabilitation with exercise after myocardial infarction, Circulation, vol.80, issue.2, pp.234-244, 1989.
DOI : 10.1161/01.CIR.80.2.234

W. Haskell, E. Alderman, and J. Fair, Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP), Circulation, vol.89, issue.3, pp.975-990, 1994.
DOI : 10.1161/01.CIR.89.3.975

D. Ornish, L. Scherwitz, and J. Billings, Intensive Lifestyle Changes for Reversal of Coronary Heart Disease, JAMA, vol.280, issue.23, pp.2001-2007, 1998.
DOI : 10.1001/jama.280.23.2001

Y. Song, J. Manson, and J. Meigs, Comparison of Usefulness of Body Mass Index Versus Metabolic Risk Factors in Predicting 10-Year Risk of Cardiovascular Events in Women, The American Journal of Cardiology, vol.100, issue.11, pp.1654-1658, 2007.
DOI : 10.1016/j.amjcard.2007.06.073

Y. He, B. Jiang, and J. Wang, BMI Versus the Metabolic Syndrome in Relation to Cardiovascular Risk in Elderly Chinese Individuals, Diabetes Care, vol.30, issue.8, pp.2128-2134, 2007.
DOI : 10.2337/dc06-2402

D. Villareal, C. Apovian, R. Kushner, and S. Klein, Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society, The American Journal of Clinical Nutrition, vol.268, issue.5, pp.923-934, 2005.
DOI : 10.1001/jama.1992.03490080092032

D. Backer, G. Ambrosioni, E. Borch-johnsen, and K. , European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts), European Heart Journal, vol.24, issue.17, pp.1601-1610, 2003.
DOI : 10.1016/S0195-668X(03)00347-6

S. Smith, A. J. Jr, and S. Blair, AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute, Circulation, vol.113, issue.19, pp.2363-2372, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.174516

S. Smith, . Jr, S. Blair, and R. Bonow, AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology, Circulation, vol.104, issue.13, pp.1581-1583, 2001.
DOI : 10.1161/hc3801.097475

S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, Age-specific relevance of usual blood pressure to vascular mortality, The Lancet, vol.361, issue.9366, pp.1903-1913, 2002.
DOI : 10.1016/S0140-6736(03)13064-4

M. Sabatine, D. Morrow, and R. Giugliano, Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes, Circulation, vol.111, issue.16, pp.2042-2049, 2005.
DOI : 10.1161/01.CIR.0000162477.70955.5F

D. Cockcroft and M. Gault, Prediction of Creatinine Clearance from Serum Creatinine, Nephron, vol.16, issue.1, pp.31-41, 1976.
DOI : 10.1159/000180580

A. Levey, J. Coresh, and T. Greene, Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate, Annals of Internal Medicine, vol.145, issue.4, pp.247-254, 2006.
DOI : 10.7326/0003-4819-145-4-200608150-00004

I. Goldenberg, I. Subirana, and V. Boyko, Relation Between Renal Function and Outcomes in Patients With Non???ST-Segment Elevation Acute Coronary Syndrome, Archives of Internal Medicine, vol.170, issue.10, pp.888-895, 2010.
DOI : 10.1001/archinternmed.2010.95

P. Steg, O. Dabbous, and L. Feldman, Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE), Circulation, vol.109, issue.4, pp.494-499, 2004.
DOI : 10.1161/01.CIR.0000109691.16944.DA

L. Wallentin, B. Lagerqvist, and S. Husted, Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial, The Lancet, vol.356, issue.9223, pp.9-16, 2000.
DOI : 10.1016/S0140-6736(00)02427-2

R. Bach, C. Cannon, and W. Weintraub, The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non???ST-Segment Elevation Acute Coronary Syndromes, Annals of Internal Medicine, vol.141, issue.3, pp.186-195, 2004.
DOI : 10.7326/0003-4819-141-3-200408030-00007

C. Terkelsen, J. Lassen, and B. Nørgaard, Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort, European Heart Journal, vol.26, issue.1, pp.18-26, 2005.
DOI : 10.1053/hj.1999.v137.89744